Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?

Zachary Klaassen, Lauren Howard, Christopher J.D. Wallis, Jessica L. Janes, Amanda De Hoedt, William J. Aronson, Thomas J. Polascik, Christopher J. Amling, Christopher J. Kane, Matthew R. Cooperberg, Martha K. Terris, Yuan Wu, Stephen J. Freedland

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?'. Together they form a unique fingerprint.

Medicine & Life Sciences